Home Capital Results

HC Surgical Specialists doubles FY2021 earnings and dividend

The Edge Singapore
The Edge Singapore7/27/2021 08:58 PM GMT+08  • 2 min read
HC Surgical Specialists doubles FY2021 earnings and dividend
The company booked fair value gains from its stakes in Medinex and Singapore Paincare Holdings too
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

HC Surgical Specialists, which focuses on endoscopic procedures, has reported earnings of $8 million for the full year ended May 31, double from $3.99 million clocked in the preceding year.

Revenue in the same period was up 39.7% to $23.36 million, thanks to “pent-up demand” after circuit breaker measures were lifted in the middle of last calendar year.

Besides enjoying one-off boosts such as the government wage subsidies, the company booked a fair value gain of $0.46 million from its direct 22.92% stake in Medinex, another listed company that specialises in providing administrative services for clinics.

HC Surgical holds shares of yet another listed company, Singapore Pain Holdings, which went public last July.

The company plans to pay a final dividend of 2.3 cents, which comes on top of the interim dividend of 1.7 cents already paid. The full year total of 4 cents is double the dividend paid for the preceding year.

“We will continue to expand our network of specialists and centres both locally and regionally when and where the opportunity arises,” says executive director and CEO Dr Heah Sieu Min (picture, left).

The company, whose other executive director is Dr Chia Kok Hoong (picture, right), now operates out of 18 clinics, including the newest one at Toa Payoh opened last December.

HC Surgical Specialist shares closed July 27 at 48 cents, down 1.03% for the day.

Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.